Science
CCR Score Could Offer ADT-Free Path in Higher-Risk Prostate Cancer – MedPage Today
Large proportion of intermediate- to high-risk patients could avoid aggressive therapy
A prognostic risk estimator that incorporates genomic data and clinical factors could allow for the elimination of androgen deprivation therapy (ADT) in some men with intermediate- or high-risk prostate cancer following radiation therapy (RT), a researcher reported.
In a retrospective validation study involving nearly 750 men who received dose-escalated RT, those with a combined clinical cell-cycle risk (CCR) score below a cutoff of 2.112 had a 10-year risk of distant metastasis of just 4.1%, regardless…
-
General17 hours agoAustralian celebrity chef Peter Russell-Clarke dies aged 89
-
General20 hours agoBack-to-back rate cuts tipped when Reserve Bank meets
-
Noosa News19 hours agoWoman left with significant arm injuries in lion attack at Darling Downs Zoo in Queensland
-
Business22 hours agoThese ASX 200 shares could rise 55% to 65%